New Zealand markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
216.12-8.77 (-3.90%)
At close: 04:00PM EST
215.62 -0.49 (-0.23%)
After hours: 05:17PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 33.67B
Enterprise value 34.34B
Trailing P/E 67.75
Forward P/E 37.74
PEG ratio (5-yr expected) 3.31
Price/sales (ttm)10.12
Price/book (mrq)11.13
Enterprise value/revenue 10.25
Enterprise value/EBITDA 30.07

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 310.96%
S&P500 52-week change 314.64%
52-week high 3301.34
52-week low 3179.37
50-day moving average 3252.49
200-day moving average 3249.50

Share statistics

Avg vol (3-month) 3497.25k
Avg vol (10-day) 3606.55k
Shares outstanding 5145.72M
Implied shares outstanding 6N/A
Float 8144.63M
% held by insiders 10.81%
% held by institutions 165.63%
Shares short (13 Jan 2022) 4790.05k
Short ratio (13 Jan 2022) 41.72
Short % of float (13 Jan 2022) 40.61%
Short % of shares outstanding (13 Jan 2022) 40.54%
Shares short (prior month 14 Dec 2021) 4738.98k

Dividends & splits

Forward annual dividend rate 41.68
Forward annual dividend yield 40.78%
Trailing annual dividend rate 30.81
Trailing annual dividend yield 30.36%
5-year average dividend yield 41.17
Payout ratio 445.63%
Dividend date 315 Dec 2021
Ex-dividend date 408 Nov 2021
Last split factor 22:1
Last split date 330 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 15.16%
Operating margin (ttm)28.48%

Management effectiveness

Return on assets (ttm)13.17%
Return on equity (ttm)17.37%

Income statement

Revenue (ttm)3.44B
Revenue per share (ttm)23.64
Quarterly revenue growth (yoy)11.90%
Gross profit (ttm)1.89B
EBITDA 1.09B
Net income avi to common (ttm)521.98M
Diluted EPS (ttm)3.55
Quarterly earnings growth (yoy)12.40%

Balance sheet

Total cash (mrq)194.48M
Total cash per share (mrq)1.33
Total debt (mrq)836.86M
Total debt/equity (mrq)26.60
Current ratio (mrq)2.49
Book value per share (mrq)21.55

Cash flow statement

Operating cash flow (ttm)577.03M
Levered free cash flow (ttm)602.06M